1981.
Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth
by Mellins, Claude A.
AIDS Care (Print), 2012, Vol.24 (8), p.953-962
1982.
HIV and schistosomiasis co-infection in African children
by Bustinduy, Amaya, MD
The Lancet infectious diseases, 2014, Vol.14 (7), p.640-649
1983.
Survival in patients with HIV infection and viral hepatitis B or C: a cohort study
by BONACINI, Maurizio
AIDS (London), 2004, Vol.18 (15), p.2039-2045
1984.
Hepatitis B and long-term HIV outcomes in coinfected HAART recipients
by HOFFMANN, Christopher J
AIDS (London), 2009, Vol.23 (14), p.1881-1889
1985.
The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa
by Andersson, M.I
Vaccine, 2013, Vol.31 (47), p.5579-5584
1986.
Barriers to care among people living with HIV in South Africa: Contrasts between patient and healthcare provider perspectives
by Bogart, Laura M.
AIDS care, 2013, Vol.25 (7), p.843-853
1987.
Chronic Medical Conditions as Risk Factors for Herpes Zoster
by Joesoef, Riduan M., MD, PhD
Mayo Clinic proceedings, 2012, Vol.87 (10), p.961-967
1988.
Containing HIV/AIDS in India: the unfinished agenda
by Chandrasekaran, Padma
The Lancet infectious diseases, 2006, Vol.6 (8), p.508-521
1989.
Endothelial activation biomarkers increase after HIV-1 acquisition: plasma vascular cell adhesion molecule-1 predicts disease progression
by Graham, Susan M
AIDS (London), 2013, Vol.27 (11), p.1803-1813
1990.
Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection
by CHOW, Felicia C
AIDS (London), 2014, Vol.28 (17), p.2573-2577
1991.
HIV in prison in low-income and middle-income countries
by Dolan, Kate, Dr
The Lancet infectious diseases, 2007, Vol.7 (1), p.32-41
1992.
Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population
by PETROVSKI, Slavé
AIDS (London), 2011, Vol.25 (4), p.513-518
1993.
Immune control of HIV-1 after early treatment of acute infection
by Walker, Bruce D
Nature (London), 2000, Vol.407 (6803), p.523-526
1994.
Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication
by QUINONES-MATEU, Miguel E
AIDS (London), 2003, Vol.17 (16), p.F39-F48
1995.
Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents
by PATEL, Kunjal
AIDS (London), 2009, Vol.23 (14), p.1893-1901
1996.
Sexual risk behaviors and psychosocial health concerns of female-to-male transgender men screening for STDs at an urban community health center
by Reisner, Sari L.
AIDS care, 2014, Vol.26 (7), p.857-864
1997.
M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication
by CASSETTA, Luca
AIDS (London), 2013, Vol.27 (12), p.1847-1856
1998.
HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era
by DEGANO, Bruno
AIDS (London), 2010, Vol.24 (1), p.67-75
1999.
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection
by WAND, Handan
AIDS (London), 2007, Vol.21 (18), p.2445-2453
2000.
Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission
by Dabis, François
AIDS (London), 2005, Vol.19 (3), p.309-318
